Table 2.
Nominal Logistic regression
| Lymphocyte recovery Day +30 | Lymphocyte recovery Day +100 | |||
| p-value (OR; 95% CI) | p-value (OR; 95% CI) | |||
| Age (≤ 9 vs. > 9 year old) | 0.01 (2.23; 1.11-4.49) | 0.3 (0.64; 0.28-1.49) | ||
| Diagnosis (ALL vs. AML) | 0.59 (1.2; 0.6-2.42) | 0.01 (3.24; 1.12-11.6) | ||
| Donor (related vs. non-related) | 0.03 (2.22; 1.10-4.47) | 0.04 (2.10; 1.08-4.79) | ||
| Disease status (early vs. advanced) | 0.02 (2.58; 1.27-5.23) | 0.6 (1.18; 0.51-2.73) | ||
| Stem cell source (CB vs. BM) | 0.008 (0.30; 0.13-0.68) | 0.58 (1.32; 0.47-3.71) | ||
| ATG use (Yes vs. no) | 0.62 (1.12; 0.56-2.62) | 0.03 (2.61; 1.06-7.06) | ||
OR: Odds ratio; 95% CI: 95% confidence interval; ALL: acute lymphoblastic leukemia; AML: acute myeloid leukemia; CB: Cord blood; BM: bone marrow; ATG: antithymocyte globulin
p-value < 0.05 denotes significant difference